Table of Contents
For global Cosmetic brands, formulation approval in one major market — the EU, the US, or Japan is often viewed as a strong indicator of product safety and compliance. In India, this assumption can be costly. The Indian regulatory framework maintains its own list of banned and restricted Cosmetic ingredients, and while it shares significant overlap with international frameworks, the differences are consequential.
India’s Cosmetics regulatory framework, governed by the Cosmetics Rules, 2020, along with applicable BIS standards including IS 4707 (Part 1 and Part 2), establishes specific requirements for prohibited ingredients, restricted substances, permitted colourants, preservatives, UV filters, and labelling obligations. While there is significant alignment with international regulations, important differences remain that can directly impact product registration and market access.
CDSCO may also issue product-specific or ingredient-specific circulars and guidelines restricting or banning specific substances. These are published through the CDSCO website and the Drugs Controller General (India)’s official communications. CosmoAlly, CliniExperts’ dedicated Cosmetics intelligence platform, tracks these updates in real time.
Hydroquinone in Leave-On Skin Lightening Products
Hydroquinone, widely used globally as a skin-lightening active, is prohibited in Cosmetic Only allowed in Artificial nail system with 0.02% in India. CDSCO issued this restriction following safety reviews that aligned India’s position with several EU and international markets. Hydroquinone may be present in products dispensed under medical supervision (as a pharmaceutical) but cannot be marketed as a Cosmetic.
Brands bringing skin-brightening or skin-lightening products into India must review all active ingredients for hydroquinone presence and reformulate if necessary, before applying for COS-2 registration.
Mercury Compounds
Cosmetics imported or manufactured in the country shall contain mercury in the following
proportions, namely, ﹘
(a) in Cosmetics intended for use only in the area of eye, the level of mercury not exceeding seventy
parts per million (0.007 per cent.) of mercury, calculated as the metal, as a preservative;
(b) in other finished Cosmetic products, unintentional mercury shall not exceed one part per million (1 ppm).
Hexachlorophene
The use of hexachlorophene in Cosmetic products is generally prohibited in India.
However, under the Cosmetics Rules, 2020, hexachlorophene may be used in soaps at a concentration not exceeding 1.0% weight by weight (w/w).
Where hexachlorophene is used in soap formulations, the following cautionary statement must appear prominently and conspicuously on the product label:
“Contains hexachlorophene – not to be used on babies.”
Chloroform
Chloroform is prohibited as a Cosmetic ingredient in India.
Colourants
Only colourants permitted under the applicable BIS standards, including IS 4707 (Part 1 and Part 2) and relevant product-specific specifications referenced in the Ninth Schedule of the Cosmetics Rules, 2020, may be used in Cosmetic products in India. Manufacturers should verify each colourant’s regulatory status, applicable restrictions, and Colour Index (CI) number before product registration.

Figure 1
| Preservative | Maximum Permitted Concentration | Usage Restriction |
| Parabens (individual) | 0.4% (as acid) in individual use | Not permitted in products intended for children under 3 or in nappy area products |
| Parabens (combined) | 0.8% (as acid) total | Same restrictions as individual limits |
| Phenoxyethanol | 1.0% | Not recommended for products intended for nappy area |
| Benzalkonium chloride | 0.1% (as benzalkonium chloride) | Not for use in aerosols |
| DMDM Hydantoin | 0.6% | Not for aerosols; formaldehyde-releasing status must be declared |
| MIT (Methylisothiazolinone) | 0.0015% (rinse-off only) | Not permitted in leave-on products |
| CMIT/MIT blend | 0.0015% | Rinse-off products only |
Table1
As discussed in Article 4, Heavy metals such as lead, arsenic, and mercury are not permitted as intentional ingredients in Cosmetic products and may only be present as unavoidable trace impurities within the limits specified in the applicable BIS standards. Manufacturers should verify compliance through finished product testing, particularly for products with higher ingestion potential, such as lip Cosmetics
UV filters used in sunscreens and other SPF-labelled Cosmetic products must comply with the applicable BIS, including IS 4707 (Part 2) and Cosmetics Rules, 2020. Manufacturers and importers should verify the regulatory status of each UV filter before product registration, as ingredients permitted in the EU, US, or other markets may not be acceptable in India.
Oxidative hair colourant ingredients — p-phenylenediamine (PPD), resorcinol, and related oxidative dyes — are subject to concentration limits and mandatory label warning requirements. p-Phenylenediamine must not exceed 2% in the final product, and the label must carry specified sensitisation warnings.
Rule 39(7) of the Cosmetics Rules, 2020 explicitly prohibits the testing of Cosmetics on animals in India. This prohibition applies to testing of the finished product and extends to Cosmetic ingredients where the testing is conducted in India.
For imported products, brands must ensure that their safety documentation does not reference animal testing conducted specifically for Cosmetic purposes — particularly for products imported from markets where Cosmetic animal testing may still occur. In practice, most global brands from EU, US, and major APAC markets will already be compliant with this requirement.
Several markets — notably the EU and the UK — have implemented or are implementing restrictions on intentionally added microplastics in Cosmetics. India has not yet implemented a blanket microplastics restriction in Cosmetics as of the time of writing, though the regulatory landscape is evolving. Brands should monitor CDSCO and BIS communications on this topic, particularly if their formulations contain polyethylene beads or other solid plastic particles.
Every formulation intended for India import registration should undergo a structured pre-filing compliance audit. CliniExperts recommends the following framework:
CliniExperts’ product and ingredient analysis service covers full BIS Ninth Schedule screening, CDSCO prohibited substance review, UV filter list verification, and preservative and colourant compliance — before you file, not after you receive a deficiency letter. We also maintain a live regulatory update tracker through our CosmoAlly platform. Contact us at contact@cliniexperts.com.
Why India’s Regulatory System is Different For companies entering India with Biological products for the first time, one of the most frequent surprises is the multiplicity of Regulatory authorit..
Learn how to use the CDSCO SUGAM Portal for Drug Import applications in India. This guide explains registration, application submission, document requirements, and compliance steps for smooth regulato..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)